ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity.
Saved in:
| Title: | ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity. |
|---|---|
| Authors: | Morazzo S; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Fernandes S; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Fortea M; European Molecular Biology Laboratory, Barcelona, Spain., Skálová H; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Pereira-Sousa D; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Cassani M; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Vrzalová K; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biochemistry, Faculty of Science, Masaryk University, Brno, Czechia., Kafka F; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Vrbský J; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia., Soulez M; Institute for Research in Immunology and Cancer, Montreal, QC, Canada., Meloche S; Institute for Research in Immunology and Cancer, Montreal, QC, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada., Morten-Seternes O; Department of Pharmacy, UIT The Arctic University of Norway, Tromso, Norway., Bosáková V; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia., Shin J; AtoGen Co., Ltd., Daejeon, Republic of Korea., Frič J; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; Institute of Hematology and Blood Transfusion, Prague, Czechia.; International Clinical Research Center (ICRC), Faculty of Medicine, Masaryk University, Brno, Czechia., Haase K; European Molecular Biology Laboratory, Barcelona, Spain., Forte G; International Clinical Research Center (ICRC), St Anne's University Hospital, Brno, Czechia.; School of Cardiovascular and Metabolic Medicine and Sciences, King's College, London, United Kingdom. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Aug 27; Vol. 15, pp. 1563969. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
